dehydrorifampicin: RN given for rifampicin quinone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 145925539 |
| MeSH ID | M0089263 |
| Synonym |
|---|
| dehydrorifampicin |
| rifaldazinequinone |
| 0oov23ti6t , |
| rifampin quinone |
| unii-0oov23ti6t |
| nsc 145633 |
| rifamycin, 1,4-dideoxy-1,4-dihydro-3-(((4-methyl-1-piperazinyl)imino)methyl)-1,4-dioxo- |
| rifamycin, 1,4-dideoxy-1,4-dihydro-3-((e)-((4-methyl-1-piperazinyl)imino)methyl)-1,4-dioxo- |
| 1,4-dideoxy-1,4-dihydro-3-((e)-((4-methyl-1-piperazinyl)imino)methyl)-1,4-dioxorifamycin |
| rifampicin impurity a [ep impurity] |
| 2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2h)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(n-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate |
| rifampin quinone [usp-rs] |
| Excerpt | Reference |
|---|---|
| " A freshly made-up solution of this labile antibiotic in a daily dosage of 20 mg/kg iv did not affect mean graft survival time in a heterotopic heart transplant model." | ( Rifampicin quinone is an immunosuppressant, but not rifampicin itself. Konrad, P; Stenberg, P, 1988) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||